Related Experiment Videos
Activation of mouse complement by monoclonal mouse antibodies
European Journal of Immunology
|December 1, 1981
Summary
Monoclonal antibodies of IgM, IgD, and IgG isotypes were tested for their ability to activate mouse complement. IgG subclasses and IgM demonstrated hemolytic activity, with IgM being more potent but less efficient in complement utilization than IgG.
Area of Science:
- Immunology
- Complement System
- Antibody Function
Background:
- Antibodies play a crucial role in the immune response by activating the complement system.
- Different antibody isotypes (IgM, IgD, IgG) exhibit distinct effector functions.
- The efficiency of complement activation can vary based on antibody isotype and genetic background.
Purpose of the Study:
- To investigate the complement-activating ability of monoclonal mouse IgM, IgD, and IgG anti-4-hydroxy-3-nitrophenyl)acetyl (NP) antibodies.
- To compare the hemolytic efficiency of different antibody isotypes and IgG subclasses.
- To determine the influence of the H-2 haplotype on complement utilization by IgM and IgG.
Main Methods:
- Hemolytic assays were performed using monoclonal antibodies against NP-conjugated sheep red blood cells.
- Complement activation was assessed by measuring red blood cell lysis.
- Experiments utilized complement from mouse strains with different H-2 haplotypes, specifically H-2k.
Main Results:
- Efficient hemolysis was observed with IgG2a, IgG2b, and IgG3 antibodies, while IgD showed no lysis.
- Some IgG1 antibodies showed weak hemolysis, while others showed none.
- IgM was a potent hemolytic agent, effective at lower concentrations than IgG.
- Under complement-limiting conditions with H-2k haplotype complement, IgG-coated cells were lysed 3-4 times more efficiently than IgM-coated cells.
- This complement utilization discrimination was H-2-linked and not observed with other H-2 alleles (b, d, s).
Conclusions:
- Mouse IgM and specific IgG subclasses (IgG2a, IgG2b, IgG3) effectively activate complement-mediated hemolysis.
- IgM is a more potent activator but less efficient in complement utilization compared to IgG.
- The efficiency of complement utilization by IgM versus IgG is modulated by a gene in the S region of the H-2 complex, particularly evident in the H-2k haplotype.